NLRP3 and myelodysplastic syndrome: Additional studies with NLRP3 specific inhibitors or using NLRP3 knockout mice in MDS mouse models such as SRSF2 (Kim et al., 2015) and SFB1 (Obeng et al., 2016) will clarify the role of NLRP3 in MDS.